argenx SE

... ...
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
VRXValeant Pharmaceuticals International, Inc. -3.89%25.4214.1%$149.57m
HZNPHorizon Therapeutics Plc -3.39%72.435.6%$140.26m
ACRSAclaris Therapeutics, Inc. -2.40%17.064.7%$125.61m
BHCBausch Health Cos., Inc. -3.52%25.520.0%$105.14m
CTLTCatalent, Inc. -2.57%110.442.1%$101.88m
JAZZJazz Pharmaceuticals Plc -1.43%163.682.4%$85.29m
SAVACassava Sciences, Inc. 3.94%20.200.0%$72.04m
AMRNAmarin Corp. Plc 6.82%7.991.5%$67.17m
GWPHGW Pharmaceuticals Plc 7.17%161.006.1%$59.22m
UTHRUnited Therapeutics Corp. -4.80%156.9414.1%$56.27m
PRGOPerrigo Co. Plc -0.45%44.296.8%$53.66m
ISRIsoRay, Inc. -8.13%1.922.5%$51.19m
ARGXargenx SE -3.25%291.210.0%$49.18m
ICPTIntercept Pharmaceuticals, Inc. 11.75%37.7516.8%$48.74m
ACSTAcasti Pharma, Inc. -9.10%0.660.2%$48.04m

Company Profile

argenx SE is a clinical-stage biotechnology company, which engages in the development of antibody-based therapies for the treatment of autoimmune diseases and cancer. Its products include ARGX-113 for the treatment of autoimmune disease myasthenia gravis and ARGX-110 for the treatment of hematological cancer acute myeloid leukemia. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren on April 25, 2008 and is headquartered in Breda, the Netherlands.